INS and Hypoglycemia: In this regard, the authors hypothesized that side effects of tirzepatide therapy (particularly vomiting) precipitated volume depletion, which, in turn, caused intermittent and inaccurate CGM sensor readings and subsequent intermittent suspensions of insulin delivery by the insulin pump due to false CGM hypoglycemia readings [129].